Oaktree Acquisition Corp. III Life Sciences (OACC) Return on Capital Employed (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Return on Capital Employed readings, the most recent being 0.6% for Q1 2026.

  • Quarterly Return on Capital Employed changed N/A to 0.6% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.6% through Mar 2026, changed N/A year-over-year, with the annual reading at 0.6% for FY2025, N/A changed from the prior year.
  • Return on Capital Employed hit 0.6% in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, roughly flat from 0.6% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.6% in Q4 2025 and bottomed at 0.6% in Q1 2026.